EQRX - EQRX Investors: Contact Robbins LLP for Information About our Investigation of EQRx Inc. | Benzinga
SAN DIEGO, Oct. 05, 2023 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP is investigating EQRx, Inc. (NASDAQ:EQRX) to determine whether certain EQRx officers and directors violated securities laws and breached fiduciary duties to shareholders.
If you would like more information about our investigation of EQRx's misconduct, click here.
EQRx, Inc. (EQRX) May Have Engaged in a Conflicted SPAC Process
EQRx International, Inc. completed a business combination with CM Life Sciences III Inc. on December 17, 2021, and now operates as EQRx, Inc. This week, Corvex Management LP agreed to pay the SEC $1 million to settle allegations that the investment advisor did not properly disclose conflicts of interests involving certain SPACs.
The SEC alleged that from July 2020 through January 2021, Corvex personnel were involved in forming three SPACs know as CM Life Sciences Inc., CM Life Sciences II Inc., and CM Life Sciences III Inc. (now EQRx, Inc.). Individuals supervised ...